HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].

AuthorsK Krüger
JournalZeitschrift fur Rheumatologie (Z Rheumatol) Vol. 66 Issue 6 Pg. 536-7 (Oct 2007) ISSN: 0340-1855 [Print] Germany
Vernacular TitleInfliximab bei Riesenzellarteriitis und Polymyalgia rheumatica ineffektiv.
PMID17849125 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab
  • Prednisone
Topics
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Double-Blind Method
  • Giant Cell Arteritis (drug therapy)
  • Humans
  • Infliximab
  • Polymyalgia Rheumatica (drug therapy)
  • Prednisone (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: